Exelixis (NASDAQ: EXEL) net income
Exelixis reported a net profit of $782.6m for fiscal 2025, 50.1% more than in fiscal 2024 ($521.3m). Its net margin was 33.7%. Earnings per share were $2.88.
Exelixis has grown its net income for 3 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2020, −65.2%. It reported a loss in 1 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $782.6m | +50.1% | 33.7% | $2.88 |
| 2024 | $521.3m | +150.9% | 24.0% | $1.80 |
| 2023 | $207.8m | +14.0% | 11.4% | $0.65 |
| 2022 | $182.3m | −21.1% | 11.3% | $0.57 |
| 2021 | $231.1m | +106.7% | 16.1% | $0.73 |
| 2020 | $111.8m | −65.2% | 11.3% | $0.36 |
| 2019 | $321.0m | −53.5% | 33.2% | $1.06 |
| 2018 | $690.1m | +347.4% | 80.8% | $2.32 |
| 2017 | $154.2m | — | 34.1% | $0.52 |
| 2016 | −$70.2m | — | −36.7% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Exelixis net income compared with its sector
By net income for its latest fiscal year, Exelixis ranks 48th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Exelixis, 33.7%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 46th | Illumina | $850.0m | 19.6% |
| 47th | Dexcom | $836.3m | 17.9% |
| 48th | Exelixis | $782.6m | 33.7% |
| 49th | Steris | $782.3m | 13.2% |
| 50th | Royalty Pharma | $770.9m | 32.4% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Exelixis
- How much did Exelixis earn in fiscal 2025?
- Exelixis reported a net profit of $782.6m for fiscal 2025. In fiscal 2024 it reported a net profit of $521.3m.
- What are the earnings per share of Exelixis?
- They were $2.88 in fiscal 2025, compared with $1.80 in fiscal 2024.
- What is the net margin of Exelixis?
- In fiscal 2025 its net profit was 33.7% of its revenue.
- What was the most profitable year for Exelixis?
- Of its last 10 fiscal years, fiscal 2025, with $782.6m.
- Where does Exelixis rank in its sector by net income?
- It ranks 48th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Exelixis come from?
- From the annual report (Form 10-K) that Exelixis files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Exelixis files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Exelixis: the Exelixis page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.